Jack Green Named Verastem CFO

Verastem, Inc.,

focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the appointment of John “Jack” Green as Chief Financial Officer. Mr. Green was the former Chief Financial Officer of GTC Biotherapeutics and has held multiple senior finance roles in public and private biotechnology companies over the course of his career. “Jack brings a great deal of experience in the financial management of biotechnology companies,” said Henri Termeer, Lead Director of Verastem. “On behalf of the entire board of directors, I welcome him and look forward to the contributions he will make.” “Cancer is an affliction that we all unfortunately have to face